The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
Year | Volume (Price x Shares) | Change |
---|---|---|
2023 | $10.2 M | -98.38% |
2022 | $0.62 B | 629.28% |
2021 | $86.13 M | -77.97% |
2020 | $0.39 B | 85.64% |
2019 | $0.21 B | -52.97% |
2018 | $0.44 B | 269.88% |
2017 | $0.12 B | -48.45% |
2016 | $0.23 B | -37.53% |
2015 | $0.37 B | -44.13% |
2014 | $0.67 B | 2387.79% |
2013 | $27.05 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Pfizer PFE | $0.23 B | $0.56 B | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $42.87 M | $0.29 B | ๐บ๐ธ USA |
![]() Amgen AMGN | $81.07 M | $0.51 B | ๐บ๐ธ USA |
![]() Biogen BIIB | $8.79 M | $65.55 M | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $33.96 M | $0.28 B | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $63.47 M | $0.22 B | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $0.11 B | $0.25 B | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | $27.64 M | $72.38 M | ๐ฌ๐ง UK |
![]() Neurocrine Biosciences
NBIX | $5.42 M | $27.48 M | ๐บ๐ธ USA |